Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Phase II trial of PS-341 in patients with renal cell cancer: a University of Chicago phase II consortium study.

Davis NB, Taber DA, Ansari RH, Ryan CW, George C, Vokes EE, Vogelzang NJ, Stadler WM. Phase II trial of PS-341 in patients with renal cell cancer: a University of Chicago phase II consortium study. J Clin Oncol. 2004 Jan 01; 22(1):115-9.

View in: PubMed

collapse authors with profiles